title: The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease.
abstract: The Princeton Consensus (Expert Panel) Conference is a multispecialty collaborative tradition dedicated to optimizing sexual function and preserving cardiovascular health. The third Princeton Consensus met November 8 to 10, 2010, and had 2 primary objectives. The first objective focused on the evaluation and management of cardiovascular risk in men with erectile dysfunction (ED) and no known cardiovascular disease (CVD), with particular emphasis on identification of men with ED who may require additional cardiologic work-up. The second objective focused on reevaluation and modification of previous recommendations for evaluation of cardiac risk associated with sexual activity in men with known CVD. The Panel's recommendations build on those developed during the first and second Princeton Consensus Conferences, first emphasizing the use of exercise ability and stress testing to ensure that each man's cardiovascular health is consistent with the physical demands of sexual activity before prescribing treatment for ED, and second highlighting the link between ED and CVD, which may be asymptomatic and may benefit from cardiovascular risk reduction.
authors.affiliation: Department of Urology, Mayo Clinic, Rochester, MN 55905, USA. Ajay_Nehra@rush.edu
authors.forename: Ajay
authors.initials: A
authors.lastname: Nehra
authors.forename: Graham
authors.initials: G
authors.lastname: Jackson
authors.forename: Martin
authors.initials: M
authors.lastname: Miner
authors.forename: Kevin L
authors.initials: KL
authors.lastname: Billups
authors.forename: Arthur L
authors.initials: AL
authors.lastname: Burnett
authors.forename: Jacques
authors.initials: J
authors.lastname: Buvat
authors.forename: Culley C
authors.initials: CC
authors.lastname: Carson
authors.forename: Glenn R
authors.initials: GR
authors.lastname: Cunningham
authors.forename: Peter
authors.initials: P
authors.lastname: Ganz
authors.forename: Irwin
authors.initials: I
authors.lastname: Goldstein
authors.forename: Andre T
authors.initials: AT
authors.lastname: Guay
authors.forename: Geoff
authors.initials: G
authors.lastname: Hackett
authors.forename: Robert A
authors.initials: RA
authors.lastname: Kloner
authors.forename: John
authors.initials: J
authors.lastname: Kostis
authors.forename: Piero
authors.initials: P
authors.lastname: Montorsi
authors.forename: Melinda
authors.initials: M
authors.lastname: Ramsey
authors.forename: Raymond
authors.initials: R
authors.lastname: Rosen
authors.forename: Richard
authors.initials: R
authors.lastname: Sadovsky
authors.forename: Allen D
authors.initials: AD
authors.lastname: Seftel
authors.forename: Ridwan
authors.initials: R
authors.lastname: Shabsigh
authors.forename: Charalambos
authors.initials: C
authors.lastname: Vlachopoulos
authors.forename: Frederick C W
authors.initials: FC
authors.lastname: Wu
mesh_terms: D002318:Cardiovascular Diseases / Q000175:diagnosis* / Q000628:therapy*; D007172:Erectile Dysfunction / Q000175:diagnosis* / Q000628:therapy*; D017079:Exercise Tolerance; D006801:Humans; D008019:Life Style; D008297:Male; D017410:Practice Guidelines as Topic; D011322:Primary Prevention; D012017:Referral and Consultation; D018570:Risk Assessment; D040242:Risk Reduction Behavior; D012725:Sexual Behavior; D013739:Testosterone / Q000097:blood
chemical_list: D013739:Testosterone